Page 11 - Analytical Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Husband and wife team behind $220m Trajan life sciences IPO Share A decade after it was founded by husband and wife team Stephen and Angela Tomisich, analytical science and devices company Trajan Group has filed to list on the ASX with a market capitalisation of $220 million. The business, which is based in the Melbourne suburb of Ringwood, is a developer and manufacturer of analytical science instruments, devices and solutions used predominantly in healthcare, as well as food and environmental analysis. This ranges from microscope slides used to analyse breast tissue to analytical syringes a...

Visit Website Request Information/Quote Download PDF Copy Navitar is a global optical technology leader that enjoys developing new and innovative optical products that help you stay ahead of your competition. For over thirty years, we have been making highly repeatable precision optics and optical subsystems to help our customers improve efficiencies and yields in a wide variety of automated processes and research. Our optics, opto-mechanical sub-...

  MONTREAL -- Many Canadians have found refuge in food to counter loneliness during the pandemic, suggests a survey. This could partly explain the weight gain experienced by nearly half of the respondents. Of the 9,991 respondents to a recent survey conducted by Dalhousie University in Nova Scotia, in partnership with Caddle, more than half (57.9 per cent) reported unintentional weight changes since the start of the pandemic. Of the group, 42.3 per cent admitted to gaining weight. Conversely, 15.6 per cent of respondents observed no significant change when stepping on a scale. Of those ...

Anokion SA: Anokion Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officer Raj Manchanda, Ph.D., Promoted to Chief Development Officer Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced that Deborah Geraghty, Ph.D., has been promoted from chief operating officer to the role of president and chief executive officer, reporting to the Board of Directors, following John Hohneker, M.D.'s, retirement from the company. In addition, Raj Manchanda, Ph.D., has been promoted to chief development o...

Share: Industry Experts Provide Added Depth to Board of Directors and Advisory Board TransCode Therapeutics today announced that it has recently elected a Chairman of its Board of Directors, appointed two new Independent Directors to the Board, and appointed a new member to its Advisory Board. Philippe Calais, Pharm D, Ph.D., President, Chief Executive Officer and a director of MatriSys Bioscience, Inc., has been elected Chairman of the Board of Directors of TransCode. Dr. Calais has served on TransCode's Board of Directors since October 2018. With an extensive background in drug development,...